» Articles » PMID: 15147302

Two Distinct Classes of Muscarinic Action on Hippocampal Inhibitory Synapses: M2-mediated Direct Suppression and M1/M3-mediated Indirect Suppression Through Endocannabinoid Signalling

Overview
Journal Eur J Neurosci
Specialty Neurology
Date 2004 May 19
PMID 15147302
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

The cholinergic system in the CNS plays important roles in higher brain functions, primarily through muscarinic acetylcholine receptors. At cellular levels, muscarinic activation produces various effects including modulation of synaptic transmission. Here we report that muscarinic activation suppresses hippocampal inhibitory transmission through two distinct mechanisms, namely a cannabinoid-dependent and cannabinoid-independent mechanism. We made paired whole-cell recordings from cultured hippocampal neurons of rats and mice, and monitored inhibitory postsynaptic currents (IPSCs). When cannabinoid receptor type 1 (CB1) was blocked, oxotremorine M (oxo-M), a muscarinic agonist, suppressed IPSCs in a subset of neuron pairs. This suppression was associated with an increase in paired-pulse ratio, blocked by the M(2)-preferring antagonist gallamine, and was totally absent in neuron pairs from M(2)-knockout mice. When CB1 receptors were not blocked, oxo-M suppressed IPSCs in a gallamine-resistant manner in cannabinoid-sensitive pairs. This suppression was associated with an increase in paired-pulse ratio, blocked by the CB1 antagonist AM281, and was completely eliminated in neuron pairs from M(1)/M(3)-compound-knockout mice. Our immunohistochemical examination showed that M(2) and CB1 receptors were present at inhibitory presynaptic terminals of mostly different origins. These results indicate that two distinct mechanisms mediate the muscarinic suppression. In a subset of synapses, activation of M(2) receptors at presynaptic terminals suppresses GABA release directly. In contrast, in a different subset of synapses, activation of M(1)/M(3) receptors causes endocannabinoid production and subsequent suppression of GABA release by activating presynaptic CB1 receptors. Thus, the muscarinic system can influence hippocampal functions by controlling different subsets of inhibitory synapses through the two distinct mechanisms.

Citing Articles

Synaptic Targets and Cellular Sources of CB1 Cannabinoid Receptor and Vesicular Glutamate Transporter-3 Expressing Nerve Terminals in Relation to GABAergic Neurons in the Human Cerebral Cortex.

Somogyi P, Horie S, Lukacs I, Hunter E, Sarkany B, Viney T Eur J Neurosci. 2025; 61(1):e16652.

PMID: 39810425 PMC: 11733414. DOI: 10.1111/ejn.16652.


Ghrelin Recruits the Endocannabinoid System to Modulate Food Reward.

Edwards A, DeSante S, Spencer C, Hyland L, Smith A, Sankhe A J Neurosci. 2025; 45(9).

PMID: 39779372 PMC: 11867019. DOI: 10.1523/JNEUROSCI.1620-24.2024.


Cholinergic Control of GnRH Neuron Physiology and Luteinizing Hormone Secretion in Male Mice: Involvement of ACh/GABA Cotransmission.

Vastagh C, Farkas I, Csillag V, Watanabe M, Kallo I, Liposits Z J Neurosci. 2024; 44(12).

PMID: 38320853 PMC: 10957212. DOI: 10.1523/JNEUROSCI.1780-23.2024.


2-AG-Mediated Control of GABAergic Signaling Is Impaired in a Model of Epilepsy.

Colangeli R, Morena M, Werner A, Thompson R, van der Stelt M, Pittman Q J Neurosci. 2022; 43(4):571-583.

PMID: 36460464 PMC: 9888507. DOI: 10.1523/JNEUROSCI.0541-22.2022.


Cortical control of chandelier cells in neural codes.

Jung K, Choi Y, Kwon H Front Cell Neurosci. 2022; 16:992409.

PMID: 36299494 PMC: 9588934. DOI: 10.3389/fncel.2022.992409.